Sign In
Buy ARGX
$844.50
+13.71 (+1.65%)
At Close: Aug 04, 2026
Piper Comments On Increased Interest To Invest In Arcturus, 'Incrementally Positive' On Argenx
03:58pm, Tuesday, 22'nd Mar 2022
Piper Sandler noted that Arcturus Therapeutics Holdings Inc's (NASDAQ: ARCT) recently filed 10-K mentions funding of $25 million from a "pharmaceutical company" to run a clinical trial for LUNAR-CO
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout
12:31pm, Tuesday, 22'nd Mar 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Merck's Keytruda Monotherapy Approved For A Type Of Endometrial Cancer
Merck & Co., Inc. (NYSE: MRK) s
Argenx's Subcutaneous Efgartigimod At Par With Intravenous Administration In Neuromuscular Disorder
12:30pm, Tuesday, 22'nd Mar 2022
Argenx SE (NASDAQ: ARGX) ) has announced topline data from the Phase 3 ADAPT-SC study evaluating subcutaneous (SC) efgartigimod for generalized myasthenia gravis (gMG). Myasthenia gravis is a chr
What 8 Analyst Ratings Have To Say About argenx
04:02pm, Monday, 07'th Mar 2022 Benzinga
argenx (NASDAQ:ARGX) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
3
4
0
0
Last 30D
0
0
1
argenx SE: Dutch Biotech Has Near Gain Ahead Says Hedging By Market-Makers
05:50am, Monday, 07'th Mar 2022 Seeking Alpha
argenx SE appears to be a logical buy preference now for investors seeking near-term capital gain. Read more to see why.
argenx SE: Dutch Biotech Has Near Gain Ahead Says Hedging By Market-Makers
05:50am, Monday, 07'th Mar 2022 Seeking Alphaargenx SE: Dutch Biotech Has Near Gain Ahead Says Hedging By Market-Makers
12:50am, Monday, 07'th Mar 2022
argenx SE: Dutch Biotech Has Near Gain Ahead Says Hedging By Market-Makers
argenx SE (ARGX) Q4 2021 Earnings Call Transcript
09:30pm, Thursday, 03'rd Mar 2022 The Motley Fool
ARGX earnings call for the period ending December 31, 2021.
argenx SE (ARGX) Q4 2021 Earnings Call Transcript
09:30pm, Thursday, 03'rd Mar 2022 The Motley Fool
ARGX earnings call for the period ending December 31, 2021.
argenx SE (ARGX) CEO Tim Van Hauwermeiren on Q4 2021 Results - Earnings Call Transcript
08:13pm, Thursday, 03'rd Mar 2022 Seeking Alpha
argenx SE 2021 Q4 - Results - Earnings Call Presentation
04:59pm, Thursday, 03'rd Mar 2022 Seeking Alphaargenx SE (ARGX) CEO Tim Van Hauwermeiren on Q4 2021 Results - Earnings Call Transcript
03:13pm, Thursday, 03'rd Mar 2022
argenx SE (ARGX) CEO Tim Van Hauwermeiren on Q4 2021 Results - Earnings Call Transcript
Argenx SE GAAP EPS of -$7.99 beats by $0.26, revenue of $497.28M misses by $7.93M
06:17am, Thursday, 03'rd Mar 2022 Seeking Alpha
Argenx SE press release (ARGX): FY GAAP EPS of -$7.99 beats by $0.26.Revenue of $497.28M (+1105.8% Y/Y) misses by $7.93M.Cash, cash equivalents and current financial assets…
argenx Reports Full Year 2021 Financial Results and Provides Fourth Quarter Business Update
06:00am, Thursday, 03'rd Mar 2022 GlobeNewswire Inc.
March 3, 2022
Argenx SE Q4 2021 Earnings Preview
04:45pm, Wednesday, 02'nd Mar 2022 Seeking Alpha
Argenx SE (NASDAQ:ARGX) is scheduled to announce Q4 earnings results on Thursday, March 3rd, before market open.The consensus EPS Estimate is -$4.91 and the consensus Revenue Estimate is…
